CYTO

AcronymDefinition
CYTOCroydon Youth Theatre Organisation (UK)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Slides were then incubated with DAPK, XIAP, Bcl-2, Bax, caspase-3, Cyto c, and GAPDH antibodies, overnight in a moist chamber at 4[degrees]C, washed in PBS, and incubated with biotinylated goat anti-rat antibodies (1 : 2000, Proteintech Group).
To evaluate the genetic diversity in Kail sheep, we investigated the partial mitochondrial DNA (mtDNA) control region and entire Cytochrome b (Cyto b) gene sequences.
Detection of Cyto C release from mitochondria to cytoplasm was performed using cytoplasmic extracts prepared as described previously (23).
The company could be a huge hit for UAMS, which owns 5 percent of the firm and will receive 30 percent of any royalties that Cyto Wave receives, according to Cyto Wave spokeswoman Deah Chlsenhall.
Little plasmoid Cyto has lost his memories and must retrieve them by navigating through several dozen levels where you use his elasticity to fire him from one cell to another, eventually finding a pathway to the next level portal.
"It speaks volumes that the first thing on Republicans 'CYto do' list is to give power back to big health-insurance companies," said Jim Manley, a spokesman for Senate Majority Leader Harry Reid (D-NV).
Vidaza, a "demethylation'" agent, is thought to cause demethylation or hypomethylation of DNA in abnormal hematopoietic bone marrow cells, and to have a direct cyto toxic effect, according to the manufacturer.
(RAX258) MICHAEL BECKER - CYTOGEN CORPORATION (CYTO).
AxCell Biosciences, Newtown, Pa., a subsidiary of Cytogen Corporation (Nasdaq: CYTO), has signed a term sheet with University of Muenster (UOM) to research protein interactions associated with an undisclosed gene believed to
In-charge Department of Cyto Genetics Madam Farzana also described about different steps to pertaining to preparation of disease resistant varieties.
The study is underway at the Royal Melbourne Hospital in Australia and is being overseen by ISCO subsidiary Cyto Therapeutics Pty Ltd.
Management will also depend on the overall condition of the patient and patient's desire for treatment, clinical, sonographic and cyto pathological features, he remarked.